SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹63 Cr |
Mar2023 | ₹0.58 Cr |
Mar2022 | ₹-2.45 Cr |
Mar2017 | ₹0.83 Cr |
Mar2016 | ₹-1.08 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | 10,713.84 | |
Mar2023 | ₹0.58 Cr | Positive | |
Mar2022 | ₹-2.45 Cr | Negative | |
Mar2017 | ₹0.83 Cr | Positive | |
Mar2016 | ₹-1.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,698.6 Cr | -1.1% | -6.2% | 12.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -1.1% |
-6.2% |
12.4% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses